Introduction
============

Febrile Convulsions (FC) refer to the convulsions that occur in children between the ages of 6 months and five years, with body temperature of 38ºC or higher not resulting from Central Nervous System (CNS) infection or any metabolic imbalance without any prior afebrile seizures. This condition occurs in 2-5% of the children who are neurologically healthy.^[@B1]^ The precise cause of FC is not known, but several genetic and environmental factors have been implicated.^[@B2]^ The maximum age of FC occurrence is 14-18 months, which overlaps with the maximum prevalence of Iron Deficiency Anemia (IDA) which is 1-2 years old.^[@B3]^

IDA is the most common nutritional deficiency in the world. Iron is an important micronutrient which is used by roughly all the cells in the human body. It is well understood that iron is a cofactor for several enzymes in the body and has a role in the neurotransmitters production and function, hormonal function and DNA duplication.^[@B4]^

Iron deficiency stimulates the function of neurons and, consequently, increases the risk of convulsions.^[@B3],[@B5]^ Similar conditions are observed in Attention Deficit Hyperactivity Disorder (ADHD) and Restless Leg Syndrome (RLS).^[@B6]^ Animal studies have shown the pathophysiology of this malfunction. The relationship between IDA and FC is unknown. While some studies have shown IDA as a risk factor for the development of FC,^[@B7]-[@B10]^ this relationship has not been confirmed by other studies.^[@B5],[@B11]^ On the other hand, few reports have claimed that IDA may have a protective effect on FC development.^[@B2],[@B12],[@B13]^

With respect to the high prevalence of FC and IDA in children and considering the fact that IDA is a probable risk factor for FC occurrence, as well as controversy in previous studies on this subject, this meta-analysis is carried out to determine the role of IDA in FC development by comparing IDA and ferritin level between FC patients and controls.

Methods
=======

*Data Source*

MEDLINE (PubMed), Embase (OVID), Web of sciences (Thomson Reuters) and Google scholar were searched by NH and AA for abstracts using a combination of text words. The following index (MeSH) terms were sought for ''Iron deficiency anemia" \[MeSH Terms\] OR ''iron status'' \[All Fields\] AND ''febrile convulsion'' \[MeSH Terms\] OR ''febrile seizure'' \[All Fields\]. No limitations or time period restrictions were applied during the search. A manual search of the bibliography of the retrieved papers was also carried out and the experts in this field were contacted for additional references. The latest date for the search was on January 15, 2013.

*Study Selection*

The analysis was restricted to human studies and no restriction was placed with respect to the language ([figure 1](#F1){ref-type="fig"}). Studies, which did not follow a case-control or comparative design with clear comparative groups of cases with seizures and controls without seizures were excluded from the analysis. The studies in which the cases did not have a fever, the cases and controls having other hematologic conditions, or the controls which have had any kind of seizure were excluded. Additionally, the studies that proposed no specified criteria for defining iron deficiency were excluded. The abstracts of these articles were thoroughly checked in order to select the most appropriate investigation. Attempts were also made to identify additional articles by searching the reference lists of the studies. Authors were contacted for additional information if data were not reported in a suitable format for data synthesis. Eventually, EndNote software was used to merge the retrieved citations and eliminate the duplications.

![MOOSE flowchart showing selection of studies for meta-analysis of association between Iron Deficiency Anemia and Febrile Convulsion.](ijms-39-496-g001){#F1}

*Data Extraction*

Among the selected articles, the data in the study design, the raw number of FC patients and controls who had or had not experienced IDA, the patients' age and sex, the diagnostic criteria used for definition of IDA, and source of cases and controls were extracted independently. Any discrepancy on the suitability for inclusion of a study was resolved by discussion among the authors. ****

*Statistical Analysis*

In this analysis, STATA (v. 10) and the inverse variance model was used to calculate the overall Odds Ratio (OR), 95% confidence interval (CI) and test statistic for the relationship. Because serum ferritin was continuous measurements, we used standard mean differences (SMD) as the effect size.

Statistical heterogeneity of studies was assessed through the calculation of tau^2^ and I^2^. A random effects model was applied unless I^2^ was \<25% in which a fixed effects model would be used.^[@B14]^ To dissipate any heterogeneity, subgroup analysis was performed on IDA definition. Generation of a funnel plot and the Egger and Begg P value allowed determination of the potential publication bias. In addition, the "trim-and-fill" method was utilized to obtain the estimates of ORs corrected for a possible publication bias (metatrim command). Furthermore, the quality of the studies was evaluated using the Newcastle-Ottawa Scale (NOS).^[@B15]^ To assess the effects of the study characteristics on risk, random-effects meta-regression analyses were performed on the ORs adjusted for the year of study and each study characteristics was assessed by the Newcastle-Ottawa Scale for case-control studies.

Results
=======

*Included Studies*

The initial search for studies involving the association between FC and anemia (or iron status) yielded 1,875 articles. Yet, after reviewing the abstracts and exclusion of irrelevant and duplicated articles, 37 articles remained in the analysis ([figure 1](#F1){ref-type="fig"}). Out of the 37 examined articles, one review article,^[@B16]^ two cross-sectional studies,^[@B17],[@B18]^ two letters to the editor,^[@B4],[@B19]^ two case-control studies which included thalassemic^[@B20]^ and malaria patients,^[@B21]^ one case series,^[@B22]^ one study that compared simple and complex FC regarding IDA,^[@B23]^ one study which included FC patients and evaluated the association between the paraclinical findings (e.g. anemia) and seizure recurrence,^[@B24]^ were excluded. Additionally, one study assessing the iron status via serum iron^[@B25]^ was also excluded. Furthermore, one article^[@B7]^ was counted as two studies since it contained two different control groups (hospital and population) and the association was assessed twice. The information about the selected studies can be found in [table 1](#T1){ref-type="table"} and the assessed quality of each study using NOS is presented in [table 2](#T2){ref-type="table"}.

###### 

Information about the included articles in the final meta-analysis

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **First author and year of publication**   **Iron deficiency anemia (IDA) criteria**                                                                                   **Kind of febrile convulsion (FC)**   **Cases**   **Controls**   **OR**\        **Case source**                                         **Control source**   **Age range and (mean age of cases)**
                                                                                                                                                                                                                                          **(95% CI)**                                                                                
  ------------------------------------------ --------------------------------------------------------------------------------------------------------------------------- ------------------------------------- ----------- -------------- -------------- ------------------------------------------------------- -------------------- ---------------------------------------
  Kobrinsky et al.,^[@B12]^ 1995             Hb\<11 g/dl                                                                                                                 Simple FC                             26          25             0.39\          Hospital                                                Hospital             6-36 m/o\
                                                                                                                                                                                                                                          (0.1-1.5)                                                                                   (18.9±7.6)

  Pisacane et al.,^[@B7]^ 1996               Hb\<10.5 g/dl, MCV\<70 fL, Serum Iron\<5.4 µmol/L                                                                           unknown                               146         146            2.57\          Hospital                                                Hospital             6-24 m/o\
                                                                                                                                                                                                                                          (1.43-4.59)                                                                                 (15±5.6)

  Pisacane et al.,^[@B7]^ 1996               Hb\<10.5 g/dl, MCV\<70 fL, Serum Iron\<5.4 µmol/L                                                                           unknown                               146         147            3.3\           Hospital                                                Population           6-24 m/o\
                                                                                                                                                                                                                                          (1.78-6.11)                                                                                 (15±5.6)

  Daoud et al.,^[@B26]^ 2002                 Hb\<11 g/dl                                                                                                                 First FC\                             75          75             1.46\          Hospital                                                Hospital             18.8 m/o
                                                                                                                                                                         Simple (n=66)\                                                   (0.73-2.93)                                                                                 
                                                                                                                                                                         Complex (n=9)                                                                                                                                                

  Guzman et al.,^[@B9]^ 2005                 Hb\<2SD of normal value for age                                                                                             First FC                              40          40             3.89\          Hospital                                                Hospital             3 m/o--5 y/o
                                                                                                                                                                                                                                          (1.53-9.87)                                                                                 

  Rehman et al.,^[@B8]^ 2005                 Hb\<10 g/dl                                                                                                                 First FC                              30          30             7.67\          Hospital                                                Hospital             8-36 m/o\
                                                                                                                                                                                                                                          (2.42-24.24)                                                                                (22.97±9.52)

  Al-Zwaini et al.,^[@B27]^ 2006             Hct\<33%                                                                                                                    First and recurrent FC                100         100            2.66\          Hospital                                                Hospital             6-60 m/o\
                                                                                                                                                                                                                                          (1.46-4.84)                                                                                 (25.8±15.19)

  Talebian et al.,^[@B28]^ 2008              Hb\<2SD of normal value for age                                                                                             Simple FC (n=56)\                     60          60             0.62\          Hospital                                                Hospital             under 5 y/o
                                                                                                                                                                         Complex FC (n=4)                                                 (0.23-1.63)                                                                                 

  Abaskhanian et al.,^[@B13]^ 2009           Hb and Hct\<2 SD of normal values for age^a^                                                                                First simple FC                       100         100            0.48\          Hospital                                                Hospital             6 m/o-5 y/o\
                                                                                                                                                                                                                                          (0.27-0.85)                                                                                 (21.9±14.1)

  Hartfield et al.,^[@B3]^ 2009              Hb\<11 g/dl, MCV\<70 fL and RDW\>15.6%                                                                                      Simple or complex FC                  361         390            1.42\          Hospital                                                Hospital             6-36 m/o
                                                                                                                                                                                                                                          (0.74-2.73)                                                                                 

  Bidabadi et al.,^[@B11]^ 2009              Hb and Hct \<2 SD of normal values for age^a^                                                                               First FC\                             200         200            0.85\          Hospital                                                Hospital             6 m/o-5 y/o\
                                                                                                                                                                         Simple (n=132)\                                                  (0.57-1.26)                                                                                 (22.86-12.86)
                                                                                                                                                                         Complex (n=68)                                                                                                                                               

  Abdurrahman et al.,^[@B29]^ 2009           Hb\<10.5 g/dl, MCV\<70 fL, serum iron\<22 μg/dl, and TIBC\>400 μg/dl                                                        First FC                              112         120            3.44\          Hospital or who visited private office of the authors   unknown              5 m/o-4 y/o
                                                                                                                                                                                                                                          (1.73-6.83)                                                                                 

  Amirsalari et al.,^[@B30]^ 2010            Hb\<10.5 g/dl                                                                                                               First FC                              132         88             0.43\          Hospital                                                Hospital             9 m/o-5 y/o
                                                                                                                                                                                                                                          (0.12-1.56)                                                                                 

  Sherjil et al.,^[@B31]^ 2010               Hb\<9 g/dl, serum ferritin\<7, MCV\<65, MCHC\<28                                                                            Unknown                               157         153            1.92\          Hospital                                                Hospital             6 m/o-6 y/o
                                                                                                                                                                                                                                          (1.14-3.23)                                                                                 

  Jun et al.,^[@B32]^2010                    Hb\<10.5 g/dl                                                                                                               First and recurrent FC\               100         100            1.64\          Hospital                                                Hospital             15.8±6.1 m/o
                                                                                                                                                                         Simple (n=59)\                                                   (0.91-2.98)                                                                                 
                                                                                                                                                                         Complex (n=41)                                                                                                                                               

  Kumari  et al.,^[@B10]^ 2012               Hb\<11 g/dL, serum ferritin\<12 and RDW\>15%                                                                                Simple FC                             154         154            5.34\          Hospital                                                Hospital             6 m/o-3 y/o\
                                                                                                                                                                                                                                          (3.27-8.74)                                                                                 (17.5±8.81)

  Derakhshanfar et al.,^[@B2]^ 2012          Hb and Hct\<2 SD of normal values for age^a^                                                                                Unknown                               500         500            0.57\          Hospital                                                Hospital             6 m/o-5 y/o\
                                                                                                                                                                                                                                          (0.45-0.74)                                                                                 (26.49+12.65)

  Heydarian et al.,^[@B5]^ 2012              Hb\<10.5 g/dl                                                                                                               First simple FC                       120         120            1.04\          Hospital                                                Hospital             6 m/o-5 y/o\
                                                                                                                                                                                                                                          (0.61-1.75)                                                                                 (20.7±14.8)

  Zareifar et al.,^[@B35]^ 2012              Hb\<2 SD of normal value for age                                                                                            Simple FC                             300         200            0.42\          Hospital                                                Hospital             6 m/o-5 y/o\
                                                                                                                                                                                                                                          (0.29-0.6)                                                                                  (26.4±13.8)

  Majumdar et al.,^[@B33]^ 2012              Hb\<11 g/dl, MCV\<70 fL, MCH\<27 pg, ferritin\<12 μg/dl, serum ferrous\<60 μg/dl, TIBC\>450 μg/dl, transferrin\<250 mg/dl   First FC                              50          50             6.29\          Hospital                                                Hospital             6 m/o-6 y/o
                                                                                                                                                                                                                                          (2.52-15.7)                                                                                 

  Sadeghzadeh et al.,^[@B34]^ 2013           Hb\<10.5 g/dl                                                                                                               First and recurrent FC\               100         100            1.3\           Hospital                                                Health care center   6 m/o-3 y/o
                                                                                                                                                                         Simple (n=70)\                                                   (0.64-2.64)                                                                                 
                                                                                                                                                                         Complex (n=30)                                                                                                                                               

  Mahyar et al.,^[@B36]^ 2006                \-                                                                                                                          First simple FC                       20          20             \-             Hospital                                                Hospital             9-24 m/o

  Salehi et al.,^[@B37]^ 2009                \-                                                                                                                          First FC                              90          90             \-             Hospital                                                Hospital             9m/o-5 y/o\
                                                                                                                                                                                                                                                                                                                                      (1.6±1.2)

  Momen et al.,^[@B39]^ 2010                 Hb\<11 g/L, MCV\<72 fL, ferritin\<20 μg/dL and TIBC\<440 μg/dL                                                              First simple FC                       50          50             \-             Hospital                                                Hospital             9 m/o-5 y/o

  Vaswani et al.,^[@B40]^ 2010               hemoglobin\<11 g /dL, MCV\<70 fL, MCH\<27 pg and serum ferritin\<12 μg/dL                                                   First FC                              50          50             \-             Hospital                                                Hospital             6 m/o-6 y/o\
                                                                                                                                                                                                                                                                                                                                      (1.73±0.94)

  Talebian et al.,^[@B38]^ 2011              \-                                                                                                                          Unknown                               40          40             \-             Hospital                                                Hospital             6 m/o-5 y/o\
                                                                                                                                                                                                                                                                                                                                      (24.8±13.95)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

OR (95% CI): Odds ratio with 95% confidence intervals; SD: Standard deviation; Hb: Hemoglobin; Hct: Hematocrit; MCV: Mean corpuscular volume; MCHC: Mean corpuscular hemoglobin concentration; TIBC: Total iron binding capacity; m/o: Months old; y/o: years old; ^a^Hb\<10.5 g/dl for 6--24 months and \<11.5 g/dl for 24--60 months old, Hct\<33% for 6--24 months and \<34% for 24--60 months old, MCV\<70 fL for 6--24 months and \<75 fL for 24--60 months old, MCH\<23 pg for 6--24 months and \<24 pg for 24--60 months old, MCHC\<30 g/dl for 6--24 months and \<31 g/dl for 24--60 months old, RBC\<3.7×10^[@B6]^ for 6--24 months and \<3.9×10^[@B6]^ for 24--60 months old, serum iron concentration \<40 mg/dl before 1 year old and \<50 mg/dl after 1 year old, PF\<7 mg/l, and TIBC\>430 mcg/dl

###### 

Quality assessment of the included studies

                                      **Quality Indicators From Newcastle-Ottawa Scale^a^**                                             
  ----------------------------------- ------------------------------------------------------- ----- ----- ----- ----- ----- ----- ----- ----
  Kobrinsky et al.,^[@B12]^ 1995      Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Pisacane1 et al.,^[@B7]^ 1996       Yes                                                     No    No    Yes   Yes   No    Yes   Yes   No
  Pisacane2 et al.,^[@B7]^ 1996       Yes                                                     No    Yes   Yes   Yes   No    Yes   Yes   No
  Daoud et al^[@B26]^, 2002           Yes                                                     No    No    Yes   Yes   No    Yes   Yes   No
  Guzman et al.,^[@B9]^ 2005          Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Rehman et al.,^[@B8]^ 2005          Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Al-Zwaini et al.,^[@B27]^ 2006      Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Talebian et al.,^[@B28]^ 2008       Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Abaskhanian et al.,^[@B13]^ 2009    Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Hartfield et al.,^[@B3]^ 2009       Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Bidabadi et al.,^[@B11]^ 2009       Yes                                                     No    No    Yes   Yes   yes   No    Yes   No
  Abdurrahman et al.,^[@B29]^ 2009    Yes                                                     No    No    Yes   Yes   Yes   No    Yes   No
  Amirsalari et al.,^[@B30]^ 2010     Yes                                                     yes   No    Yes   Yes   No    No    Yes   No
  Sherjil et al.,^[@B31]^ 2010        Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Jun et al.,^[@B32]^2010             Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Kumari et al.,^[@B10]^ 2012         Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Derakhshanfar et al.,^[@B2]^ 2012   Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Heydarian et al.,^[@B5]^ 2012       Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Zareifar et al.,^[@B35]^ 2012       Yes                                                     No    No    Yes   Yes   Yes   No    Yes   No
  Majumdar et al.,^[@B33]^ 2012       Yes                                                     No    No    Yes   Yes   No    No    Yes   No
  Sadeghzadeh et al.,^[@B34]^ 2013    Yes                                                     No    Yes   Yes   Yes   No    No    Yes   No

^a^1: Indicates cases independently validated; 2: Cases are representative of population; 3: Community controls; 4: Controls have no history of Febrile Convulsion; 5A: Study controls for age; 5B: Study controls for additional factor(s) e.g. Iron supplement, Temperature, etc.; 6: Ascertainment of exposure by blinded interview or record; 7: Same method of ascertainment used for cases and controls; 8: Non-response rate the same for cases and controls

*Anemia in FC Patients vs. Controls*

According to the results, a statistically significant association was found between anemia and FC. The overall OR upon the inclusion of all the 21 studies^2,3,5,7-13,26-35^ was 1.52 (95% CI=1.01 to 2.28) \[I^2^=89.7; P\<0.001; tau^2^=0.72\] ([figure 2](#F2){ref-type="fig"}).

![The figure demonstrates the pooled odds ratios and 95% confidence intervals for Iron deficiency anemia when comparing febrile convulsions (FC) patients with control groups and overall and subgroup analysis according to prevalence of anemia in population of studies (higher vs. lower than 40%). The studies are listed based on date](ijms-39-496-g002){#F2}

The evidence of publication bias was provided by a funnel plot. The Egger test was significant for publication bias (P=0.02) but not the Begg test (P=0.43).

The stratified analyses for anemia criteria according to the IDA definition yielded pooled OR estimates of 1.84 (95% CI=1.02 to 3.33; z=2.04; P=0.04) \[I^2^=92.7; P\<0.001; tau^2^=0.81\] for 10 studies with anemia criteria according to iron status and 1.26 (95% CI=0.73 to 2.1; z=0.84; P=0.4) \[I^2^=84.6; P\<0.001; tau^2^=0.63\] for 11 studies with anemia criteria according to Hb and hematocrit (Hct). Furthermore, the pooled OR was 0.56 (95% CI=0.42 to 0.75; z=3.87; P\<0.0001) \[I^2^=57.9; P\<0.001; tau^2^=0.05\] for 4 studies performed in the populations with a high prevalence of anemia (\>40% in the control groups), but 2.04 (95% CI=1.46 to 2.85; z=4.16; P\<0.0001) \[I^2^=73.6; P\<0.001; tau^2^=0.34\] for 17 studies conducted among those with low and moderate prevalence of anemia (\<40% in the control groups) ([figure 2](#F2){ref-type="fig"}).

The influence analyses were completed by recalculating the pooled ORs for the sample on multiple occasions, while removing one study at each iteration. These analyses were particularly important because several studies included samples that were substantially larger than most of the other studies and thus could have exerted large effects on the overall effect estimates. For all studies, these analyses yielded ORs ranging from 1.43 (95% CI=0.97 to 2.1) to 1.64 (95% CI=1.1 to 2.4).

The present analysis also assessed the relationship between the quality of the study, year of the study, IDA definition, FC definition, the prevalence of anemia in the study population and the effect size (log OR) via random effects meta-regression. This analysis showed that even after correction for these elements, the relation between IDA definition (coefficient=0.76; SE=0.36; P=0.04) and the prevalence of anemia in the study population (coefficient=-1.74; SE=0.46; P=0.003) and FC was significant (I^2^=72.7; tau^2^=0.33). Nevertheless, the regression model revealed that none of the NOS scores and the year of the study was significantly related to OR.

*Ferritin Level in FC Patients vs. Controls*

Data on ferritin level were available for 12 studies.^2,11,13,26,33,35-41^ Four studies (Daoud et al.,^[@B26]^ Momen et al.,^[@B39]^ Vaswani et al.,^[@B40]^ and Modaresi et al.^[@B41]^) reported a significant decrease in the ferritin level in FC patients. On the other hand, three studies (Abaskhanian et al.,^[@B13]^ Bidabadi et al.,^[@B11]^ Derakhshanfar et al.^[@B2]^) reported a significant increase in the ferritin level in the FC patients compared with controls. The results of a random effects model for the 12 case-control studies included in the present meta-analysis are presented in [figure 3](#F3){ref-type="fig"}. The overall Standard Mean Difference (SMD) with a 95% CI was -0.02 (-0.09 to 0.06; z=0.47; P=0.64) \[I^2^=94.4; P\<0.001; tau^2^=0.31\].

![The figure demonstrates standard mean difference (SMD) of ferritin level and 95% confidence intervals when comparing febrile convulsions (FC) patients with control groups and overall and subgroup analysis according to significance difference between temperature of case and control. The studies are listed based on date.](ijms-39-496-g003){#F3}

The publication bias was evaluated by a funnel plot. Neither Egger test (P=0.54) nor Begg test (P=0.49) was statistically significant for the publication bias.

The pooled SMD of ferritin was -0.57 (with 95% CI of -0.7 to -0.46; z=9.23; P\<0.001) \[I^2^=90.6; P\<0.001; tau^2^=0.26\] for the six studies reporting no difference between FC and control groups regarding the temperature. On the other hand, it was measured as 0.29 (95% CI=0.2 to 0.38; *z*=6.26; P\<0.001) \[I^2^=86.6; P\<0.001; tau^2^=0.04\] for the other 6 studies showing a significant difference between FC and control groups regarding temperature ([figure 3](#F3){ref-type="fig"}).

Discussion
==========

The results revealed a statistically significant relationship between FC and IDA; IDA was 1.52 times more prevalent among the FC patients compared with controls. We observed a significant heterogeneity in this meta-analysis. Some parts of this heterogeneity can be explained by variations in the demographic characteristics, the primary illness resulting in fever, fever severity (temperature), family history of seizures, selection bias (especially in the control groups), etc. ([table 1](#T1){ref-type="table"}).

Yet, meta-regression and subgroup analyses showed that the state of IDA prevalence in the control group, which should reflect the prevalence of IDA in the general population, could be one of the main reasons for the observed heterogeneity. Of course, this relationship was more significant and heterogeneity showed a decreasing trend in the subgroup analysis which did not have a high prevalence of IDA (\<40%) (OR: 2.07). In other words, the association between IDA and FC was significant in the regions with a low/medium prevalence of IDA, but not in those with a high prevalence of IDA (\>40%).

One possible explanation is that when the rate of IDA is high in a particular population, the difference between the ratio of IDA in FC patients and controls is not high enough to show a significant difference. Moreover, most studies with high rates of IDA were done in Iran. This indicates the role of genetics, besides IDA, as a cofactor in FC.^[@B2]^ In other words, since FC is a multifactorial disease, it can be concluded that genetics trigger the effects of IDA on FC.^[@B42],[@B43]^ Furthermore, reports have suggested that FC development is associated with the socio-economic level of patient's family.^[@B4],[@B44]^ It is obvious that the socio-economic status is associated with IDA; therefore, it is anticipated that IDA has an intermediate effect on FC and is a negative confounder with other factors related to low levels of socio-economic status.^[@B45]^ Overall, the associated factors with low socio-economic status includes zinc,^[@B46],[@B47]^ magnesium.^[@B48],[@B49]^ selenium,^[@B48],[@B50]^ copper deficiencies^[@B47]^ and high levels of lead.^[@B8]^

The ferritin level is affected by the severity of fever and increases with fever. In some studies, the severity of fever was not similar in the FC patients and controls. Consequently, ferritin level could not be compared between the two groups. Nonetheless, when groups with similar fever severity (temperature) were compared, ferritin level was found to be lower in the FC children compared with the healthy ones. This is consistent with other findings from our meta-analysis.

According to the findings, iron deficiency leads to dysfunction of myelination as well as tyrosine and tryptophan hydroxylase synthesis, which are necessary for neurotransmitter production as well as the release of neurotransmitters from vesicles.^[@B21],[@B51]^ The role of iron has also been documented in the production of serotonin, dopamine, and Gamma-Butyric Acid (GABA).^[@B5]^

Bradford Hill's criterion is among the best for showing a causative relationship.^[@B52],[@B53]^ Generally, it is difficult to draw conclusions about the causal relationships in observational studies. However, this meta-analysis could address some of the Hill's criteria.^[@B53]^ The strength of the association was 2.07 (in populations with low and moderate prevalence of anemia) and the criteria could be accepted. Some studies have revealed the temporality and earlier occurrence of IDA compared to FC. In most studies, the primary event was the first FC and, as a result, we can accept that IDA/iron deficiency occurred before FC. Yet, it is difficult to draw such conclusion in the studies where the evaluated event was both the first and the recurrent FC. The association between IDA/iron deficiency and FC is consistent with the current knowledge and theories (coherence criteria). The biological plausibility evidence demonstrates the role of iron as an important cofactor for normal functioning of the brain neurotransmitters. However, limited data are available on the biological gradient between the cause (IDA) and the effect (FC). Therefore, further study on this topic is recommended. Since FC is a multi-factorial disease, specificity criteria cannot be adhered. According to these criteria, IDA should only cause an effect (FC) to be concluded as a cause for FC. Evidence regarding the administration of iron for FC children has also been controversial and requires more research.^[@B20],[@B54],[@B55]^ Overall, it can be stated that IDA causes FC through a similar mechanism that causes ADHD, Breath Holding Spells (BHS) and RLS (analogy).^[@B6]^

In addition to the observational nature of the articles used here, this meta-analysis had other limitations. First, the quality of some of the articles was not high enough. For example, the characteristics of the drop out patients were not clear. Besides, in most of the studies, data gathering was not done in a blinded fashion and selection of the patients was hospital-based rather than population-based.^[@B56]^ Additionally, the patients were not selected randomly in few studies. Furthermore, in a few studies, the two study groups were not similar regarding the important factors and the role of the confounding variables was not well controlled. Thus, we attempted to control the role of the quality of these items using meta-regression. Another limitation of this meta-analysis was different markers and definitions for IDA and FC. The odds ratio of heterogeneity was large between the studies and some part of this heterogeneity might be related to different definitions of IDA and/or FC. We tried to control this issue by performing a meta-regression analysis and then subgroup analysis. The funnel plot indicated the lack of symmetry and the possibility of bias. However, using "trim and fill" sensitivity analysis, no considerable change was observed in the results indicating the low level of bias in the performed meta-analysis.

Further high-quality studies (cohort or case-control) are recommended on this topic. In future studies, IDA and FC should be defined more precisely and the role of the important factors, such as socio-economic status and the serum levels of zinc, manganese, lead, etc., should be controlled to determine whether the association between IDA and FC is causal or not. After documenting a causative relationship, interventional studies can also be performed to assess the effect of iron administration on the FC patients.

Conclusion
==========

Thus far, the combined results of the case control studies suggest that iron deficiency anemia is associated with a moderate increased risk of FC in children, particularly in areas with low and moderate prevalence of anemia. Future work should be carried out on interventional studies and the implication for public health.
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